Non-invasive Glioma Characterization Through Molecular Imaging
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Miami
About this trial
MRI-based sequences can provide non-invasive quantification of intratumoral 2-hydroxyglutarate (2HG) distribution and tumor cellularity in human gliomas and help guide the development of novel glioma therapies.
Eligibility criteria
Qualifiers
Adults (≥18 year old)
Subjects with suspected or confirmed gliomas and who will have a medically indicated biopsy or resection of his/her brain lesion.
Disqualifiers
Adults unable to consent
Individuals who are not yet adults (infants, children, teenagers)
Pregnant women
Patients unable to have MRI done
Trial design
Treatments tested in this trial
- 3T MRI Scanner
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov